险资方向，本期较上一期持股增加的险资共计1个，即泰康资管-建设银行-泰康资产盈泰成长资产管理 产品，持股增加占比达0.4%。。本期较上一季度持股减少的险资共计2个，包括泰康人寿保险有限责任 公司-投连-多策略优选、泰康人寿保险有限责任公司-投连-优选成长，持股减少占比达1.0%。 外资态度来看，本期较上一期持股增加的外资基金共计1个，即香港中央结算有限公司，持股增加占比 达0.26%。 公募基金方面，本期较上一季未再披露的公募基金共计204个，主要包括南方中证1000ETF、招商量化 精选股票发起式A、华夏中证1000ETF、广发中证1000ETF、招商成长量化选股股票A等。 2025年10月28日，云图控股(002539.SZ)发布2025年第三季报。截至2025年10月27日，共有9个机构投资 者披露持有云图控股A股股份，合计持股量达1.20亿股，占云图控股总股本的9.94%。其中，机构投资 者包括四川蓝剑投资管理有限公司、银河德睿资本管理有限公司、泰康资管-建设银行-泰康资产盈泰成 长资产管理产品、泰康人寿保险有限责任公司-投连-优选成长、香港中央结算有限公司、泰康人寿保险 有限责任公司-投连-多策略优 ...

公募基金方面，本期较上一期持股增加的公募基金共计1个，即广发量化多因子混合A，持股增加占比 达0.46%。本期较上一季度持股减少的公募基金共计2个，包括招商量化精选股票发起式A、招商成长量 化选股股票A，持股减少占比达1.36%。本期较上一季未再披露的公募基金共计104个，主要包括华安安 信消费混合A、华安精致生活混合A、华安汇嘉精选混合A、华安聚嘉精选混合A、诺安多策略混合A 等。 以上内容与数据，与有连云立场无关，不构成投资建议。据此操作，风险自担。 2025年10月28日，达意隆(002209.SZ)发布2025年第三季报。截至2025年10月27日，共有6个机构投资者 披露持有达意隆A股股份，合计持股量达2874.43万股，占达意隆总股本的14.44%。其中，机构投资者 包括深圳乐丰投资管理有限公司、中国银行股份有限公司-招商量化精选股票型发起式证券投资基金、 中国建设银行股份有限公司-广发量化多因子灵活配置混合型证券投资基金、BARCLAYS BANK PLC、 中国光大银行股份有限公司-招商成长量化选股股票型证券投资基金、招商基金管理有限公司-社保基金 一五零三组合，机构投资者合计持股比例达14. ...

Core Insights - Kelu Electronics (002121.SZ) reported its Q3 2025 financial results on October 25, 2025, highlighting significant institutional investor interest [1] Institutional Holdings - As of October 24, 2025, five institutional investors disclosed holdings in Kelu Electronics A-shares, totaling 669 million shares, which represents 40.30% of the company's total share capital [1] - The institutional ownership increased by 2.10 percentage points compared to the previous quarter [1] Public Fund Activity - In this reporting period, 29 public funds were not disclosed compared to the previous quarter, including notable funds such as China Merchants Quantitative Selected Stock A and GF Quantitative Multi-Factor Mixed A [1] Foreign Investment - One foreign fund, Hong Kong Central Clearing Limited, increased its holdings in Kelu Electronics, with an increase of 2.11% compared to the previous period [1]

2025年10月25日，华正新材(603186.SH)发布2025年第三季报。截至2025年10月24日，共有7个机构投资 者披露持有华正新材A股股份，合计持股量达6703.15万股，占华正新材总股本的47.20%。其中，机构 投资者包括华立集团股份有限公司、全国社保基金六零一组合、交通银行股份有限公司-易方达科讯混 合型证券投资基金、交通银行股份有限公司-易方达科融混合型证券投资基金、中国建设银行股份有限 公司-易方达创新驱动灵活配置混合型证券投资基金、易方达基金管理有限公司-社保基金17042组合、 中国银行股份有限公司-易方达成长动力混合型证券投资基金，机构投资者合计持股比例达47.20%。相 较于上一季度，机构持股比例合计上涨了4.66个百分点。 对于社保基金，本期新披露持有华正新材的社保基金共计2个，包括全国社保基金六零一组合、易方达 基金管理有限公司-社保基金17042组合。 以上内容与数据，与有连云立场无关，不构成投资建议。据此操作，风险自担。 公募基金方面，本期较上一季度新披露的公募基金共计4个，包括易方达科讯混合、易方达科融混合、 易方达创新驱动混合、易方达成长动力混合A。本期较上一季未再披 ...

Group 1 - The core viewpoint of the news is that Dailong (002209.SZ) has seen an increase in institutional investor holdings, indicating growing confidence in the company [1] - As of August 21, 2025, 22 institutional investors disclosed holding a total of 37.93 million shares of Dailong, accounting for 19.06% of the total share capital [1] - The top ten institutional investors collectively hold 18.84% of the shares, with their combined holding ratio increasing by 5.07 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, two public funds increased their holdings, accounting for 1.34% of the total [2] - A total of 18 new public funds were disclosed compared to the previous quarter, including several notable funds such as Huaxia Ruipan Taili Mixed A and the Southern CSI 500 Quantitative Enhanced Stock Initiation A [2] - One new foreign institution, UBS AG, was disclosed this quarter, while Morgan Stanley & Co. International PLC was not disclosed in the current period [2]

Core Viewpoint - Lianhuan Pharmaceutical's stock experienced a significant drop, reaching the daily limit down on July 15, indicating potential market concerns regarding the company's performance and investor sentiment [1]. Company Overview - Lianhuan Pharmaceutical Co., Ltd. was established in December 1999, originating from Yangzhou Pharmaceutical Factory founded in 1958, and is recognized as a national high-tech enterprise engaged in research, production, and sales [1]. Shareholder Activity - Two funds under China Merchants Fund have entered the top ten shareholders of Lianhuan Pharmaceutical, holding a combined stake of 0.88%. Specifically, the China Merchants Quantitative Selected Stock A fund increased its holdings in the first quarter of this year, while the China Merchants Growth Quantitative Stock Selection A fund made a new entry [1]. - The China Merchants Quantitative Selected Stock A fund has achieved a year-to-date return of 20.03%, ranking 138 out of 992 in its category, while the China Merchants Growth Quantitative Stock Selection A fund has a year-to-date return of 15.45%, ranking 229 out of 992 [1]. Fund Performance Comparison - The performance of the China Merchants Quantitative Selected Stock A fund over various periods is as follows: - 1-week increase: 3.04% - 1-month increase: 8.72% - 3-month increase: 18.07% - 6-month increase: 21.12% - Year-to-date increase: 20.03% [2]. - In comparison, the average return of similar funds and the CSI 300 index shows lower performance, indicating that the China Merchants Quantitative Selected Stock A fund is outperforming its peers [2]. Fund Manager Profile - Wang Ping, the fund manager for both the China Merchants Quantitative Selected Stock A and the China Merchants Growth Quantitative Stock Selection A funds, has extensive experience in investment risk management and quantitative analysis, having joined China Merchants Fund in 2006 [5][6].

Group 1 - The core viewpoint of the news is that Dailong (002209.SZ) has reported its annual results for 2024, highlighting the current institutional investor holdings and changes in share ownership [1] - As of April 9, 2025, a total of 15 institutional investors disclosed holdings in Dailong A-shares, with a combined holding of 26.7169 million shares, representing 13.42% of the total share capital [1] - The top ten institutional investors collectively hold 13.41% of the shares, with a decrease of 0.88 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one fund, Yimin Quality Upgrade Mixed A, reported a slight decrease in holdings compared to the previous quarter [2] - A total of 11 new public funds were disclosed this period, including several funds from招商 and西部利得 [2] - One foreign institution, J.P. Morgan Securities PLC- proprietary funds, was not disclosed in this period compared to the previous quarter [2]